Kamada

Healthcare · Drug Manufacturers - Specialty & Generic

8.30$ +1.3% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

Kamada (KMDA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 383 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet KMDA
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	95	100	93	100	112	122	121	124	115	138	145	156	157	174	197	206	206	211	211	216	217	319	303	304	320	322	317	314	337	355	343	351	351	372	375	368	377	379	383	383
Current Assets	74	77	70	76	88	97	95	99	91	111	114	126	127	144	166	175	175	178	175	179	179	130	116	119	135	139	131	130	153	170	158	166	164	184	189	183	193	193	199	200
Cash	6.5	10.0	11	11	12	13	17	12	13	18	22	24	27	43	49	57	52	70	61	68	100	19	22	30	31	34	27	22	53	56	48	57	72	78	76	66	72	75	33	29
Cash & Short-Term Investments	27	29	29	27	40	43	48	45	45	51	56	62	67	74	96	105	100	109	109	105	100	19	22	30	31	34	27	22	53	56	48	57	72	78	76	66	72	75	73	70
Receivables	19	21	14	25	25	31	19	27	17	29	27	29	26	25	28	23	32	23	24	30	31	36	22	18	24	28	25	25	25	21	19	26	21	23	34	35	35	29	41	37
Inventory	28	26	28	24	23	21	28	27	29	29	32	36	34	43	42	48	43	43	41	45	48	72	65	65	73	73	80	80	74	88	84	79	72	79	78	82	85	85	85	87
Property, Plant & Equipment	21	22	23	24	24	25	25	25	24	25	29	28	28	29	28	28	29	29	29	29	29	29	29	29	29	29	–	32	33	–	–	–	–	–	–	–	–	–	–	–
Goodwill	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	30	–	–	–	30	–	–	–	30	–	–	–	30	30	30	30	30	30	30
Intangible Assets	–	21	–	–	–	–	–	–	–	0.1	–	–	–	0.3	–	–	1.5	1.5	–	–	–	123	152	150	149	117	145	144	143	110	139	137	135	102	101	100	99	96	96	94
Total Liabilities	26	33	30	32	28	33	30	28	21	26	28	32	26	38	31	36	30	32	29	34	35	142	128	133	147	146	142	138	99	111	97	100	96	113	123	108	112	110	124	114
Current Liabilities	19	27	25	27	24	29	27	25	19	24	22	27	21	33	25	30	23	25	22	26	27	54	42	50	69	76	69	66	37	50	37	41	34	49	57	46	48	47	60	49
Short-Term Debt	0.4	0.4	0.4	0.5	0.6	0.6	0.6	0.6	0.6	0.6	1.4	1.9	1.5	1.5	1.4	1.4	1.4	1.3	1.2	1.2	1.2	3.8	4.7	5.5	5.4	5.5	5.9	5.5	1.1	1.4	1.5	1.5	1.6	1.6	1.8	1.9	1.9	2.1	2.2	2.3
Accounts Payable	8.9	16	15	14	12	18	17	16	12	17	15	20	13	25	18	23	15	16	15	18	19	25	12	18	31	33	26	28	13	25	16	20	15	28	25	25	25	23	22	28
Long-Term Debt	1.5	1.4	1.3	1.4	1.5	1.4	1.2	1.0	0.9	0.7	4.6	4.5	4.5	0.3	0.1	0.1	0.0	0.0	0.0	0.0	–	17	16	15	14	13	12	11	–	–	–	–	–	–	–	–	–	–	–	–
Shareholders' Equity	69	67	63	68	84	89	90	96	94	112	117	124	130	135	166	170	177	179	181	182	182	177	175	172	173	176	175	177	238	244	247	251	255	259	252	260	265	269	259	270
Retained Earnings	-110	-111	-115	-111	-111	-105	-104	-98	-101	-83	-78	-72	-66	-61	-56	-52	-46	-44	-41	-40	-41	-46	-48	-52	-51	-48	-50	-48	-45	-40	-38	-33	-30	-26	-33	-26	-21	-17	-27	-18
Shares Outstanding	35	36	36	37	40	40	42	41	40	40	41	41	42	41	43	35	46	41	45	47	42	46	46	44	48	45	45	45	54	57	57	55	55	54	57	57	59	62	59	58

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings